BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 28212752)

  • 1. Caspase-8 Acts in a Non-enzymatic Role as a Scaffold for Assembly of a Pro-inflammatory "FADDosome" Complex upon TRAIL Stimulation.
    Henry CM; Martin SJ
    Mol Cell; 2017 Feb; 65(4):715-729.e5. PubMed ID: 28212752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cFLIP
    Davidovich P; Higgins CA; Najda Z; Longley DB; Martin SJ
    Cell Rep; 2023 Dec; 42(12):113476. PubMed ID: 37988267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAIL Receptors Serve as Stress-Associated Molecular Patterns to Promote ER-Stress-Induced Inflammation.
    Sullivan GP; O'Connor H; Henry CM; Davidovich P; Clancy DM; Albert ML; Cullen SP; Martin SJ
    Dev Cell; 2020 Mar; 52(6):714-730.e5. PubMed ID: 32109381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adaptor protein FADD and the initiator caspase-8 mediate activation of NF-κB by TRAIL.
    Grunert M; Gottschalk K; Kapahnke J; Gündisch S; Kieser A; Jeremias I
    Cell Death Dis; 2012 Oct; 3(10):e414. PubMed ID: 23096115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redundant and receptor-specific activities of TRADD, RIPK1 and FADD in death receptor signaling.
    Füllsack S; Rosenthal A; Wajant H; Siegmund D
    Cell Death Dis; 2019 Feb; 10(2):122. PubMed ID: 30741924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death.
    Jaco I; Annibaldi A; Lalaoui N; Wilson R; Tenev T; Laurien L; Kim C; Jamal K; Wicky John S; Liccardi G; Chau D; Murphy JM; Brumatti G; Feltham R; Pasparakis M; Silke J; Meier P
    Mol Cell; 2017 Jun; 66(5):698-710.e5. PubMed ID: 28506461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABT-737 induces expression of the death receptor 5 and sensitizes human cancer cells to TRAIL-induced apoptosis.
    Song JH; Kandasamy K; Kraft AS
    J Biol Chem; 2008 Sep; 283(36):25003-13. PubMed ID: 18599488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual role of DR5 in death and survival signaling leads to TRAIL resistance in cancer cells.
    Shlyakhtina Y; Pavet V; Gronemeyer H
    Cell Death Dis; 2017 Aug; 8(8):e3025. PubMed ID: 29048428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade.
    Das S; Tripathi N; Preet R; Siddharth S; Nayak A; Bharatam PV; Kundu CN
    Oncotarget; 2017 Jan; 8(1):248-267. PubMed ID: 27542249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2.
    Hartwig T; Montinaro A; von Karstedt S; Sevko A; Surinova S; Chakravarthy A; Taraborrelli L; Draber P; Lafont E; Arce Vargas F; El-Bahrawy MA; Quezada SA; Walczak H
    Mol Cell; 2017 Feb; 65(4):730-742.e5. PubMed ID: 28212753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of Death Receptor 5 and Production of Reactive Oxygen Species Mediate Sensitization of PC-3 Prostate Cancer Cells to TRAIL Induced Apoptosis by Vitisin A.
    Shin D; Kwon HY; Sohn EJ; Nam MS; Kim JH; Lee JC; Ryu SY; Park B; Kim SH
    Cell Physiol Biochem; 2015; 36(3):1151-62. PubMed ID: 26111475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAIL receptor gene editing unveils TRAIL-R1 as a master player of apoptosis induced by TRAIL and ER stress.
    Dufour F; Rattier T; Constantinescu AA; Zischler L; Morlé A; Ben Mabrouk H; Humblin E; Jacquemin G; Szegezdi E; Delacote F; Marrakchi N; Guichard G; Pellat-Deceunynck C; Vacher P; Legembre P; Garrido C; Micheau O
    Oncotarget; 2017 Feb; 8(6):9974-9985. PubMed ID: 28039489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas.
    Bellail AC; Tse MC; Song JH; Phuphanich S; Olson JJ; Sun SY; Hao C
    J Cell Mol Med; 2010 Jun; 14(6A):1303-17. PubMed ID: 19432816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling.
    Harper N; Hughes MA; Farrow SN; Cohen GM; MacFarlane M
    J Biol Chem; 2003 Nov; 278(45):44338-47. PubMed ID: 12920112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer.
    Yang J; Li G; Zhang K
    Biomed Pharmacother; 2016 Dec; 84():1078-1087. PubMed ID: 27780136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble TNF-like weak inducer of apoptosis (TWEAK) enhances poly(I:C)-induced RIPK1-mediated necroptosis.
    Anany MA; Kreckel J; Füllsack S; Rosenthal A; Otto C; Siegmund D; Wajant H
    Cell Death Dis; 2018 Oct; 9(11):1084. PubMed ID: 30349023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic "Achilles heel" for the TrkAIII oncoprotein in neuroblastoma.
    Gneo L; Ruggeri P; Cappabianca L; Farina AR; Di Ianni N; Mackay AR
    Oncotarget; 2016 Dec; 7(49):80820-80841. PubMed ID: 27821809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the CYLD/RIPK1/FADD/caspase-8-dependent apoptosis.
    Yang C; Ran Q; Zhou Y; Liu S; Zhao C; Yu X; Zhu F; Ji Y; Du Q; Yang T; Zhang W; He S
    Apoptosis; 2020 Jun; 25(5-6):441-455. PubMed ID: 32418059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCTAIRE1-knockdown sensitizes cancer cells to TNF family cytokines.
    Yanagi T; Shi R; Aza-Blanc P; Reed JC; Matsuzawa S
    PLoS One; 2015; 10(3):e0119404. PubMed ID: 25790448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of RIP and c-FLIP in preventing liver cancer cell apoptosis induced by TRAIL.
    Sun J; Luo H; Nie W; Xu X; Miao X; Huang F; Wu H; Jin X
    Int J Clin Exp Pathol; 2015; 8(6):6519-25. PubMed ID: 26261530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.